Understanding Anemia: Definition, Classification, Causes, and Management
Definition and Classification of Anemia
Anemia is defined as a reduction of the hemoglobin (Hb) concentration, red-cell count, or packed cell volume below normal levels. 1
Anemia is diagnosed when hemoglobin levels fall below:
Anemia severity is classified as 1:
- Mild: Hb ≥10 g/dL and ≤11.9 g/dL
- Moderate: Hb ≥8.0 g/dL and ≤9.9 g/dL
- Severe: Hb <8.0 g/dL
Epidemiology of Anemia
- Anemia affects approximately one-third of the world's population 3
- In cancer patients, anemia of chronic disease is present in about 40% of cases 1
- In heart failure patients, anemia prevalence increases with disease severity, affecting 25-40% of patients 1
- Anemia is more common in women, elderly people, and patients with chronic diseases 1, 3
- In children, iron deficiency anemia has an incidence of 20.1% between 0-4 years in industrialized countries 4
Etiology and Pathophysiology
Anemia can result from three main mechanisms 5:
Blood loss (acute or chronic) 4, 5:
- Gastrointestinal bleeding
- Heavy menstrual bleeding
- Trauma
- Surgical procedures
Decreased red blood cell production 5:
Increased red blood cell destruction 5:
- Hemolytic anemias
- Genetic disorders (thalassemia, sickle cell disease)
- Autoimmune conditions
Specific Types of Anemia
Iron Deficiency Anemia (IDA)
- Most common type of anemia worldwide 4, 3
- Caused by inadequate iron intake, poor absorption, or blood loss 4
- Diagnosis confirmed by 1:
- Low serum ferritin (<30 μg/L without inflammation)
- Low transferrin saturation (<16%)
- In presence of inflammation, ferritin <100 μg/L suggests iron deficiency
Anemia of Chronic Disease (ACD)
- Second most common cause of anemia 1
- Associated with chronic inflammatory conditions, infections, cancer 1
- Diagnostic criteria include 1:
- Serum ferritin >100 μg/L
- Transferrin saturation <16%
- Evidence of underlying chronic disease
Anemia in Heart Failure
- Present in 25-40% of heart failure patients 1
- Associated with increased mortality risk (approximately doubled) 1
- Causes include iron deficiency, renal dysfunction, and chronic inflammation 1
- Negatively impacts exercise capacity and quality of life 1
Anemia in Cancer
- Prevalence varies by cancer type (highest in lung and gynecological cancers) 1
- Causes include chemotherapy-induced bone marrow suppression, bleeding, nutritional deficiencies, and chronic inflammation 1
- Significantly impacts quality of life and may affect treatment outcomes 1
Diagnostic Approach
Initial Evaluation
- Complete blood count (CBC) with red cell indices 1
- Reticulocyte count to assess bone marrow response 1
- Iron studies (serum iron, ferritin, transferrin saturation) 1
- Vitamin B12 and folate levels 1
- Inflammatory markers (C-reactive protein) 1
- Renal function tests 1
- Peripheral blood smear examination 1
Additional Testing Based on Clinical Suspicion
- Bone marrow examination when indicated 1
- Assessment for occult blood loss in stool and urine 1
- Coombs testing in suspected hemolytic anemia 1
- Hemoglobin electrophoresis for suspected hemoglobinopathies 5
- Endogenous erythropoietin levels in suspected myelodysplasia 1
Management Principles
Iron Deficiency Anemia
- Oral iron supplementation is first-line therapy 1, 4
- Intravenous iron may be necessary in cases of poor absorption, intolerance to oral iron, or when rapid correction is needed 1
- In patients with iron deficiency anemia having elective non-cardiac surgery, preoperative iron therapy (oral or IV) is reasonable to reduce blood transfusions and increase hemoglobin 1
- Identify and treat the underlying cause (e.g., GI bleeding, heavy menstrual bleeding) 4
Anemia in Heart Failure
- Treatment of anemia in heart failure patients may improve quality of life and functional capacity 1
- Iron deficiency should be corrected even in the absence of anemia 1
- Consider erythropoiesis-stimulating agents in selected cases 1
Anemia in Cancer
- Erythropoiesis-stimulating agents (ESAs) may be considered in chemotherapy-induced anemia 1
- Blood transfusions for severe symptomatic anemia 1
- Iron supplementation when iron deficiency is present 1
Blood Transfusions
- Generally reserved for severe symptomatic anemia or acute blood loss 1
- Restrictive transfusion threshold (Hb <8 g/dL) is recommended for most patients 1
- Transfusion threshold of 7 g/dL may be appropriate in stable patients 1
- Higher thresholds may be considered in patients with acute coronary syndrome 1
Prevention Strategies
- Regular screening for high-risk populations 1
- Iron supplementation during pregnancy 1
- Nutritional education and iron-rich diet promotion 1
- Prompt treatment of conditions that may lead to blood loss 4
- Regular monitoring of hemoglobin levels in patients with chronic diseases 1
Special Considerations
Anemia in Pregnancy
- Physiologic hemodilution causes a natural decline in hemoglobin during pregnancy 1
- Iron requirements increase significantly during pregnancy 1
- High hemoglobin (>15.0 g/dL) in the second trimester may indicate poor blood volume expansion and is associated with adverse outcomes 1
Anemia in the Elderly
- Often multifactorial (nutritional deficiencies, chronic disease, unexplained anemia) 2
- Associated with increased morbidity and mortality 2
- Unexplained anemia accounts for approximately one-third of cases in the elderly 2